The major findings of our study can be summarized as follows: The most robust BA.1-directed neutralizing antibody response and BA.1-specific CD4+ T-cell response was observed in the cohort of transplant recipients with Omicron-BA.1 infection, with immune responses comparable to immunocompetent triple-vaccinated controls. This evidence concerns the gene CD4 and infection.